Abstract
The nuclear phosphoprotein c-Jun is a major component of the AP-1 transcription factor, whose activity is augmented by many oncogenes. An important mechanism to stimulate AP-1 function is N-terminal phosphorylation of c-Jun at the serine residues 63 and 73 by the c-JunN-terminal kinases (JNKs). Mice and cells harboring a mutant allele of c-jun, which has the JNK phosphoacceptor serines changed to alanines (junAA), were used to determine the function of c-Jun N-terminal phosphorylation (JNP) during oncogenic transformation in vitro and in vivo. JunAA immortalized fibroblasts expressing v-ras and v-fos showed reduced tumorigenicity in nude mice, but the efficiency of v-src transformation was unaffected by the lack of JNP. To assess the significance of JNP in tumour development in vivo, two transgenic mouse tumour models were employed. Skin tumour development caused by constitutive activation of the ras pathway by K5-SOS-F expression and c-fos-induced osteosarcoma formation were impaired in mice lacking JNP. Inhibition of JNP may, therefore, be a novel therapeutic strategy to inhibit tumour growth in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Angel P and Karin M . 1991 Biochem Biophys Acta 1072: 129–157
Arias J, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M, Feramisco J and Montminy M . 1994 Nature 370: 226–229
Aronheim A, Engelberg D, Li N, al-Alawi N, Schlessinger J and Karin M . 1994 Cell 78: 949–961
Bannister AJ, Oehler T, Wilhelm D, Angel P and Kouzarides T . 1995 Oncogene 11: 2509–2514
Behrens A, Sibilia M and Wagner EF . 1999 Nat Genet 21: 326–329
Binetruy B, Smeal T and Karin M . 1991 Nature 351: 122–127
Bos TJ, Bohmann D, Tsuchie H, Tjian R and Vogt PK . 1988 Cell 52: 705–712
Boulter CA and Wagner EF . 1988 Oncogene 2: 207–214
Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessinger J, Wigler MH and Bar-Sagi D . 1993 Science 260: 1338–1343
Curran T, MacConnell WP, van Straaten F and Verma IM . 1983 Mol Cell Biol 3: 914–921
Derijard B, Hibi M, Wu IH, Barrett T, Su B, Dent T, Karin M and Davis RJ . 1994 Cell 76: 1025–1037
Eferl R, Sibilia M, Hilberg F, Fuchsbichler A, Kufferath I, Guertl B, Zenz R, Wagner EF and Zatloukal K . 1999 J Cell Biol 145: 1049–1061
Grigoriadis AE, Schellander K, Wang ZQ and Wagner EF . 1993 J Cell Biol 122: 685–701
Johnson R, Spiegelman B, Hanahan D and Wisdom R . 1996 Mol Cell Biol 16: 4504–4511
Johnson RS, van Lingen B, Papaioannou VE and Spiegelmann BM . 1993 Genes Dev 7: 1309–1317
Joneson T and Bar-Sagi D . 1997 J Mol Med 75: 587–593
Karin M . 1996 Philos Trans R Soc Lond B Biol Sci 351: 127–134
Keller G, Paige C, Gilboa E and Wagner EF . 1985 Nature 318: 149–154
Kovary K and Bravo R . 1991 Mol Cell Biol 11: 4466–4472
Kovary K and Bravo R . 1992 Mol Cell Biol 12: 5015–5023
Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J and Woodgett JR . 1994 Nature 369: 156–160
Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJ, Pass HI, Picci P, Levine AS and Carbone M . 1996 J Cell Biochem 63: 37–50
Rappolee DA, Mark D, Banda MJ and Werb Z . 1988 Science 241: 708–712
Redmond SM, Reichmann E, Muller RG, Friis RR, Groner B and Hynes NE . 1988 Oncogene 2: 259–265
Rutberg SE, Saez E, Glick A, Dlugosz AA, Spiegelman BM and Yuspa SH . 1996 Oncogene 13: 167–176
Sabapathy K, Hu Y, Kallunki T, Schreiber M, David JP, Jochum W, Wagner EF and Karin M . 1999 Curr Biol 9: 116–125
Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH and Spiegelman BM . 1995 Cell 82: 721–732
Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P and Wagner EF . 1999 Genes Dev 13: 607–619
Schuh AC, Keating SJ, Monteclaro FS, Vogt PK and Breitman ML . 1990 Nature 346: 756–760
Sibilia M, Fleischmann A, Behrens A, Stingl L, Carroll J, Watt F, Schlessinger J and Wagner EF . 2000 submitted
Smeal T, Binetruy B, Mercola D, Grover-Bardwick A, Heidecker G, Rapp UR and Karin M . 1992 Mol Cell Biol 12: 3507–3513
Smeal T, Binetruy B, Mercola DA, Birrer M and Karin M . 1991 Nature 354: 494–496
Todaro GJ, Lazar GK and Green H . 1965 J Cell Physiol 66: 325–333
Van Beveren C, van Straaten F, Curran T, Muller R and Verma IM . 1983 Cell 32: 1241–1255
Vogt PK . 1992 Cancer 69: 2610–2614
Wagner EF, Vanek M and Vennstrom B . 1985 EMBO J 4: 663–666
Wang ZQ, Liang J, Schellander K, Wagner EF and Grigoriadis AE . 1995 Cancer Res 55: 6244–6251
Wisdom R, Johnson RS and Moore C . 1999 EMBO J 18: 188–197
Young MR, Li JJ, Rincon M, Flavell RA, Sathyanarayana BK, Hunziker R and Colburn N . 1999 Proc Natl Acad Sci USA 96: 9827–9832
Yuspa SH . 1998 J Dermatol Sci 17: 1–7
Acknowledgements
We thank Svetlana Pekez for maintaining the mouse colony. We are also grateful to Uta Moehle-Steinlein for technical assistance, to Moshe Yaniv for antibodies, to Gerhard Christofori, Thomas Jenuwein and Laura Stingl for critical reading of the manuscript and to Hannes Tkadletz for help with preparing the illustrations. Supported in part by the Austrian Federal Ministry of Science, Transport and the Arts and the Austrian Industrial Research Promotion Fund.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Behrens, A., Jochum, W., Sibilia, M. et al. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 19, 2657–2663 (2000). https://doi.org/10.1038/sj.onc.1203603
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203603
Keywords
This article is cited by
-
An intrinsic temporal order of c-JUN N-terminal phosphorylation regulates its activity by orchestrating co-factor recruitment
Nature Communications (2022)
-
c-Jun overexpression in CAR T cells induces exhaustion resistance
Nature (2019)
-
Short-term activation of the Jun N-terminal kinase pathway in apoptosis-deficient cells of Drosophila induces tumorigenesis
Nature Communications (2018)
-
Exogenous avian leukosis virus-induced activation of the ERK/AP1 pathway is required for virus replication and correlates with virus-induced tumorigenesis
Scientific Reports (2016)
-
Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development
Targeted Oncology (2016)